Original paper
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Volume: 130, Issue: 12, Pages: 6409 - 6416
Published: Aug 18, 2020
Abstract
BACKGROUND. Patients with coronavirus disease 2019 (COVID-19) develop pneumonia generally associated with lymphopenia and a severe inflammatory response due to uncontrolled cytokine release. These mediators are transcriptionally regulated by the JAK/STAT signaling pathways, which can be disabled by small...
Paper Details
Title
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Published Date
Aug 18, 2020
Volume
130
Issue
12
Pages
6409 - 6416